— Know what they know.
Not Investment Advice
Also trades as: BOI.PA (PAR) · $vol 0M · 0DTF.L (LSE) · $vol 0M

BOIRF OTC

Boiron S.A.
1W: +0.0% 1M: +0.0% 3M: -1.2% YTD: +5.0% 1Y: +10.5% 3Y: +0.2% 5Y: -2.2%
$31.50
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $546.9M mcap · 3M float · 0.0003% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$546.9M
52W Range24.5-32.28
Volume200
Avg Volume8
Beta0.22
Dividend$1.57
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOPascal Houdayer
Employees2,634
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1996-05-02
Websiteboiron.com
2, avenue de l’Ouest Lyonnais
Messimy 69510
FR
33 4 78 45 61 00
About Boiron S.A.

Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North America, and numerous international territories. The company's offerings comprise a diverse array of homeopathic products, including both non-proprietary and branded formulations. Notable examples from its brand portfolio target specific health concerns: Oscillococcinum is formulated to alleviate symptoms associated with influenza, such as fever, chills, headaches, and general body aches. Stodal and Stodaline are designed for the symptomatic relief of coughs. Arnigel provides topical support for minor, non-open traumatic injuries. Camilia is specifically developed to soothe teething discomfort in infants. Sédatif PC addresses anxiety, emotional imbalances, and mild sleep disturbances. Coryzalia helps manage cold symptoms and rhinitis. Homéoptic offers relief for various types of eye irritation and discomfort in both adults and children. Homéovox is aimed at vocal disorders. Beyond its core homeopathic line, Boiron provides a range of supplementary health products. These include dietary supplements; the Dermoplasmine collection (available as stick, balm, and mousse) for dry lips and skin; Mag' Nuit, designed to aid sleep; Arnitrosium for joint pain; Castor Equi Boiron ointment to treat cracked skin; and Storinil, a syrup for cold treatment. Furthermore, the company produces herbal medicines, such as Canephron, which supports increased urine production and improved urinary elimination. Its product list also features moisturizing baby milk and a selection of medical devices, including COVID-19 self-tests and rapid antigenic tests. Boiron distributes its extensive product portfolio through a wide network, encompassing its own distribution centers, independent pharmacies, large pharmacy chains, wholesalers, grocery stores, specialized health food retailers, and online sales platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms